ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

OMB Backs Down, May Release New Construction Funds For UCLA, Salk, NYU

April 25, 1975

ESAs Increase Risk of Death by 11 Percent, Blood Clots by 59 Percent, Meta-Analysis Finds; Study To Be Updated At ASCO.

June 1, 2007

NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s

December 12, 1997

DCT Board Approves Reissuing Surgical Oncology RFA For Planning, Okays New Recompleting Projects

June 17, 1983

Quality Of Care Varies Widely For Prostate Cancer, Study Says

August 29, 2008

BRCA2 Carriers Reduced BC Risk By Prophylactic Surgery

June 30, 2006